4-Year Results: Tislelizumab Plus Chemo for Esophageal Cancer
In a groundbreaking development within the arena of oncology, new data emerging from the phase 2 TD-NICE clinical trial reveals ...
In a groundbreaking development within the arena of oncology, new data emerging from the phase 2 TD-NICE clinical trial reveals ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine